tiprankstipranks
Advertisement
Advertisement

Moolec Science Wins Nasdaq Extension After Equity Boost from Subsidiary Bankruptcies

Story Highlights
  • Nasdaq granted Moolec Science an exception until June 29, 2026 to regain compliance with its minimum stockholders’ equity listing requirement.
  • Bankruptcies of several subsidiaries in late 2025 triggered derecognition gains and share conversions that significantly increased Moolec’s equity, which it believes restores Nasdaq compliance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Moolec Science Wins Nasdaq Extension After Equity Boost from Subsidiary Bankruptcies

Claim 55% Off TipRanks

Moolec Science ( (MLEC) ) just unveiled an announcement.

On January 22, 2026, Moolec Science S.A. announced that a Nasdaq Hearings Panel has granted the company an exception until June 29, 2026 to demonstrate compliance with Nasdaq’s minimum stockholders’ equity requirement under Listing Rule 5550(b)(1), subject to certain disclosure conditions. The company’s equity position improved after bankruptcy filings by several subsidiaries at the end of December 2025 triggered derecognition events under IFRS 10, allowing Moolec to recognize estimated gains of about $91.0 million from loss of control of Bioceres S.A., $5.2 million from Bioceres LLC, and $4.6 million from Theo I SCSp, alongside the recognition of previously eliminated intercompany balances and the conversion of certain preference shares into ordinary shares; Moolec believes these changes have already brought it back into compliance with Nasdaq’s equity standards and has notified the exchange as it continues working to maintain its listing.

The most recent analyst rating on (MLEC) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.

Spark’s Take on MLEC Stock

According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.

The score is primarily held down by weak financial performance (large losses, cash burn, negative equity and higher debt) and bearish technicals (below key moving averages with negative MACD). Valuation provides limited offset because the negative P/E is driven by losses and there is no dividend support.

To see Spark’s full report on MLEC stock, click here.

More about Moolec Science

Moolec Science S.A. is a Cayman Islands–incorporated company listed on Nasdaq, operating in the broader biotechnology and agri-food sector, and is subject to U.S. securities regulation as a foreign private issuer under Form 20-F reporting standards.

Average Trading Volume: 303,506

Technical Sentiment Signal: Sell

Current Market Cap: $3.19M

Find detailed analytics on MLEC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1